Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. (MTNB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MTNB · as of Jun 8, 2026
Key Statistics
Explore Matinas BioPharma Holdings, Inc. Data
mtnb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 87.5%
Competitors & Peers
mtnb competitorsMTNB
ACXP
ADIL
ADXN
BCLI
CDIOStock Performance
Full HistoryAbout Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovati…
what is matinas biopharma holdings, inc. · mtnb stock overview · matinas biopharma holdings, inc. company profile · who is matinas biopharma holdings, inc. ceo · mtnb AMEX · matinas biopharma holdings, inc. headquarters · matinas biopharma holdings, inc. business segments
About Stock Overview & Key Data
Matinas BioPharma Holdings, Inc. (MTNB) is a Healthcare company in the Biotechnology industry, listed on AMEX since Jul 21, 2014. As of the latest trading session, MTNB stock price is $0.83, with a market capitalization of $4.6M. The stock has returned -8.53% over the past 12 months and +37.35% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Matinas BioPharma Holdings, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Matinas BioPharma Holdings, Inc. reported revenue of — and net income of -$10.3M. For detailed data — including Matinas BioPharma Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Matinas BioPharma Holdings, Inc. (MTNB) stock price is $0.83. The stock is traded on AMEX under the ticker symbol MTNB. The 52-week range is $0.48 – $3.09.